重要性是模型對已發布報導給出的 1–5 分，不是對市場的預測。
已排定事件列上的影響是公司顯著度層級（高/中由圖譜中心度與規模判定；低僅用於人工整理的次要事件），不是對波動幅度的預測。
標記為已確認的財報日期，是 Yahoo Finance 認定由公司確認的；預估表示尚未公布。未加標記的列沒有可查的出處記錄。
經濟數據發布屬於總體經濟、不歸屬任何產業，因此在任何檢視下都會保留。沒有數值的發布表示尚未公布，頁面會直說，而不是顯示為零。
涵蓋被追蹤公司的即將到來的事件；已過去的事件會歸檔，並在可得時補上結果——這些結果都經人工整理並附引用，絕不杜撰。沒有結果的歷史列會顯示「結果待定」。
閉鎖期屆滿或指數調整的列會多出一行算術——將變得可賣出的股數，或指數基金必須買進的股數，以佔流通股的比例表示——依招股說明書或指數編製方法讀出，兩個數字都在該列註明出處。它陳述的是機制，不是價格走勢。由 IPO + 180 天推算出的閉鎖期日期會一直標為預估，直到公司自己說明為止。
10月14日週三 · 今天
10月15日週四
10月13日週二
合作
Adani Enterprises and Jabil signed a non-binding MoU setting out the framework for a proposed 50:50 joint venture to manufacture and assemble AI and data center equipment in India. The venture is expected to have multi-gigawatt AI rack manufacturing capacity and remains subject to definitive agreements and applicable approvals.
融資
Cipher Digital announced a proposed private offering of $850.0 million of 0.00% convertible senior notes due 2032, with a 13-day option for the initial purchasers to buy up to an additional $150.0 million. Concurrently it expects to exchange a portion of its 1.75% convertible senior notes due 2030 for common stock, and plans to use the proceeds for capped call transactions, additional equity investment in its Barber Lake project and its HPC build-out.
Exhibit 99.2 Cipher Digital Announces Proposed Private Offering of $850.0 Million of 0.00% Convertible Senior Notes Due 2032 and Concurrent Exchange of Convertible Senior Notes Due 2030 NEW YORK – October 13, 2026 – Cipher Digital Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”), a leading developer, owner and operator of industrial-scale data centers, today announced its intention to offer, subject to market and other conditions, $850.0 million aggregate principal amount of 0.00% convertible senior notes due 2032 (the “notes”) in a private offerin…
合作
Fermi said it signed a credit support agreement with AMD supporting a lease for phase one of its Project Matador energy and AI buildout in Carson County, Texas, with 222 megawatts of gross power capacity, calling it a key milestone toward securing project financing. The companies also signed an agreement outlining a partnership and framework for future expansion of up to 650 MW of gross power capacity; the release says AMD's obligations under the agreement are subject to conditions.
合作
Netflix secured exclusive rights in Spain and Andorra to the FIFA World Cup 2030, covering all 104 matches live. One match per matchday will be free in Spain, and a package including every Spain match, both semi-finals and the final will also be made available on a national free-to-air broadcaster.
Skip to content Back to All News Netflix Secures Exclusive Rights in Spain and Andorra to the FIFA World Cup 2030™ Entertainment 13 October 2026 Global Spain Link copied to clipboard Netflix Will Bring All 104 Matches of the 100th Anniversary Tournament to Fans in Spain and Andorra Netflix has secured the exclusive rights in Spain and Andorra to the FIFA World Cup 2030™, bringing all 104 matches of the world’s biggest football tournament live to Netflix. The FIFA World Cup 2030™ will mark the 100th anniversary of the tournament, with defending World Cup champion Spain serving as one of the tou…
合作
Enodia Therapeutics entered a research collaboration and license agreement with Pfizer to discover and develop Sec61 inhibitor small molecules against multiple collaboration targets; after the collaboration term Pfizer will be responsible for all clinical, manufacturing, regulatory and commercial activities. Enodia will receive an upfront payment and is eligible for milestone payments and tiered royalties, bringing the total potential value to more than $500 million.
Enodia Therapeutics Announces Research Collaboration and License Agreement with Pfizer to Develop Sec61-Targeting Small Molecules Oct 13, 2026 | Featured , Press release PARIS – Oct. 13, 2026 – Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, today announced it has entered into a research collaboration and license agreement with Pfizer Inc. to discover and develop Sec61 inhibitors. The collaboration aims to accelerate the discovery and advancement of novel small-molecule therapeutics leveraging En…
